Literature DB >> 27655215

See-Thru-Gonad zebrafish line: developmental and functional validation.

Christopher Presslauer1, Teshome Tilahun Bizuayehu1, Komeil Razmi1, Jorge M O Fernandes1, Igor Babiak2.   

Abstract

Zebrafish are an important model species in developmental biology. However, their potential in reproductive biology research has yet to be realized. In this study, we established See-Thru-Gonad zebrafish, a transparent line with fluorescently labeled germ cells visible throughout the life cycle, validated its gonadal development features, and demonstrated its applicability by performing a targeted gene knockdown experiment using vivo-morpholinos (VMOs). To establish the line, we crossed the zf45Tg and mitfa(w2/w2); mpv17(b18/b18) zebrafish lines. We documented the in vivo visibility of the germline-specific fluorescent signal throughout development, from gametes through embryonic and juvenile stages up to sexual maturity, and validated gonadal development with histology. We performed targeted gene knockdown of the microRNA (miRNA) miR-92a-3p through injection of VMOs directly to maturing ovaries. After the treatment, zebrafish were bred naturally. Embryos from miR-92a-3p knockdown ovaries had a significant reduction in relative miR-92a-3p expression and a higher percentage of developmental arrest at the 1-cell stage as compared with 5-base mismatch-treated controls. The experiment demonstrates that See-Thru-Gonad line can be successfully used for vertical transmission of the effects of targeted gene knockdown in ovaries into their offspring.
© 2016 Society for Reproduction and Fertility.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27655215     DOI: 10.1530/REP-16-0328

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  1 in total

1.  Dynamics of miRNA transcriptome during gonadal development of zebrafish.

Authors:  Christopher Presslauer; Teshome Tilahun Bizuayehu; Martina Kopp; Jorge M O Fernandes; Igor Babiak
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.